KARS1 and breast cancer: Activity of MetRS from homogenates of tumors was increased by four fold in human colon cancer comparing to adjacent normal tissue [56], GlyRS up-regulation was reported in papillary thyroid carcinoma [57], and LysRS is overexpressed in breast cancer [58].